These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22389004)

  • 1. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.
    Saxena R; Welt CK
    Acta Diabetol; 2013 Jun; 50(3):451-7. PubMed ID: 22389004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
    Barber TM; Bennett AJ; Gloyn AL; Groves CJ; Sovio U; Ruokonen A; Martikainen H; Pouta A; Taponen S; Weedon MN; Hartikainen AL; Wass JA; Järvelin MR; Zeggini E; Franks S; McCarthy MI
    Eur J Hum Genet; 2007 Jun; 15(6):679-84. PubMed ID: 17342155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.
    Saxena R; Georgopoulos NA; Braaten TJ; Bjonnes AC; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jun; 30(6):1454-9. PubMed ID: 25904635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes.
    Kim JJ; Choi YM; Cho YM; Hong MA; Chae SJ; Hwang KR; Hwang SS; Yoon SH; Moon SY
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):439-45. PubMed ID: 22443257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
    Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome.
    Wehr E; Schweighofer N; Möller R; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Metabolism; 2010 Apr; 59(4):575-80. PubMed ID: 19913856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome.
    Barber TM; Bennett AJ; Groves CJ; Sovio U; Ruokonen A; Martikainen H; Pouta A; Hartikainen AL; Elliott P; Lindgren CM; Freathy RM; Koch K; Ouwehand WH; Karpe F; Conway GS; Wass JA; Järvelin MR; Franks S; McCarthy MI
    Diabetologia; 2008 Jul; 51(7):1153-8. PubMed ID: 18478198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
    Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.
    Christopoulos P; Mastorakos G; Gazouli M; Panidis D; Deligeoroglou E; Katsikis I; Papadias K; Diamandi-Kandarakis E; Creatsas G
    Gynecol Endocrinol; 2008 Sep; 24(9):486-90. PubMed ID: 18958766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
    Biyasheva A; Legro RS; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2617-25. PubMed ID: 19351735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication study of
    Dadachanji R; Sawant D; Patil A; Mukherjee S
    Gynecol Endocrinol; 2021 Aug; 37(8):716-720. PubMed ID: 33779462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome.
    Pau CT; Mosbruger T; Saxena R; Welt CK
    PLoS One; 2017; 12(1):e0168870. PubMed ID: 28068351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
    Cui L; Zhao H; Zhang B; Qu Z; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Wang P; Li T; Shi Y; Chen ZJ
    Hum Reprod; 2013 Feb; 28(2):538-44. PubMed ID: 23208300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of variants on type-2 diabetes risk genes identified through genomewide association studies in polycystic ovary syndrome: a case-control study.
    Ezzidi I; Mtiraoui N; Mohmmed Ali ME; Masoudi AA; Abu Duhier F
    J Genet; 2018 Dec; 97(5):1213-1223. PubMed ID: 30555071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
    Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
    Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry.
    Welt CK; Styrkarsdottir U; Ehrmann DA; Thorleifsson G; Arason G; Gudmundsson JA; Ober C; Rosenfield RL; Saxena R; Thorsteinsdottir U; Crowley WF; Stefansson K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1342-7. PubMed ID: 22547425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.
    Liu Q; Tang B; Zhu Z; Kraft P; Deng Q; Stener-Victorin E; Jiang X
    Diabetologia; 2022 Sep; 65(9):1483-1494. PubMed ID: 35771237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.